d, they will be attached to "carriers" and tested in mice to determine whether they can actually elicit antibodies that neutralize the pathogen. Dr. Vitetta said the challenge and novelty of this approach is to demonstrate that these anti-peptoid antibodies can mimic those the body produces against the actual native pathogen and confer protective immunity.
"This is high-risk, high-impact research, meaning that there is a high risk of failure," Dr. Vitetta said. "But if our experiments are successful, we hope to identify peptoid mimetics that recognize all variants of HIV, and if we are extremely lucky, we will have a useful vaccine for HIV, which will have tremendous impact. Our work could also open the door for vaccines against other pathogens, such as West Nile virus, hepatitis C and influenza. Even if we fail entirely, we will gain a great deal of insight into what we need to do to make mimetic vaccines work."
'/>"/>
Page: 1 2 Related biology news :1.
RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report2.
Waste from gut bacteria helps host control weight, UT Southwestern researchers report3.
Antidepressants need new nerve cells to be effective, UT Southwestern researchers find4.
Limiting fructose may boost weight loss, UT Southwestern researcher reports5.
UT Southwestern researchers identify new targets for RNAs that regulate genes6.
UT Southwestern researchers create molecule that nudges nerve stem cells to mature7.
Geology and biology meet in the history of US southwestern desert surface waters8.
Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research9.
Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find10.
UT Southwesterns Mangelsdorf elected to National Academy of Sciences11.
NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic